New Key Statistics Module, Z-Score and F-Score
OTCPK:GBCS Key Ratios
| Market Cap $ M | 6.13 |
| Enterprise Value $ M | 42.98 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.17 |
| Price/Free Cash Flow | 12.05 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 35.00 |
| EPS (TTM) $ | -1.30 |
| Beneish M-Score | -2.81 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -108.10 |
| EV-to-EBIT | -23.92 |
| EV-to-EBITDA | -328.13 |
| PEG | -- |
| Shares Outstanding M | 3.07 |
| Net Margin (%) | -11.29 |
| Operating Margin % | -5.95 |
| Pre-tax Margin (%) | -11.29 |
| Quick Ratio | 0.27 |
| Current Ratio | 0.27 |
| ROA % (ttm) | -8.98 |
| ROE % (ttm) | -305.51 |
| ROIC % (ttm) | -4.65 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.20 |
GBCS Number of Guru Trades
GBCS Volume of Guru Trades
Gurus Latest Trades with OTCPK:GBCS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:GBCS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Selectis Health Inc Insider Transactions
No Available Data
News about OTCPK:GBCS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers